You have 9 free searches left this month | to do more

ambrisentan

Ambrisentan is a drug used to treat Pulmonary Hypertension, Systemic Sclerosis, Idiopathic Pulmonary Fibrosis, and other conditions. Ambrisentan is being actively studied in 5 studies and prior, has been studied in 27.

Top SponsorsTop SitesTop Investigators
Gilead SciencesBaylor College of MedicineAaron Waxman MD PhD
GlaxoSmithKlineGSK Investigational SiteAbdullah Kutlar
Medical University of South CarolinaMayo ClinicAri Cedars
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Not yet recruiting
  • Pulmonary Arterial Hypertension
  • Ambrisentan
  • Placebo
  • (no location specified)
2021-07-13
Jul 13, 2021
N
Terminated
  • Pre-Pulmonary Atrial Hypertension
  • Ambrisentan
  • Denver, Colorado
    National Jewish Health
2021-01-15
Jan 15, 2021
T
Completed
  • Portopulmonary Hypertension
  • Ambrisentan
  • La Jolla, California
  • +5 more
2020-12-16
Dec 16, 2020
U
Terminated
  • Pulmonary Hypertension
  • Heart Failure With Preserved Ejection Fraction
  • Ambrisentan
  • Placebo
  • Dallas, Texas
    UT Southwestern Medical Center
2020-05-15
May 15, 2020
N
Recruiting
  • Covid19
  • Hypoxemia
  • Ambrisentan
  • Placebo
  • Gijón, Asturias, Spain
  • +10 more
2021-08-04
Aug 4, 2021
U
Completed
  • Systemic Sclerosis
  • +2 more
  • Ambrisentan
  • Los Angeles, California
    David Geffen School of Medicine, University of California, Los A
2020-10-28
Oct 28, 2020
N
Terminated
  • Cirrhosis
  • +2 more
  • Ambrisentan
  • Barcelona, Catalunya, Spain
  • +5 more
2021-02-23
Feb 23, 2021
G
Completed
  • Hypertension, Pulmonary
  • Ambrisentan
  • (no location specified)
2020-09-02
Sep 2, 2020
G
Active, not recruiting
  • Hypertension, Pulmonary
  • Ambrisentan
  • Aurora, Colorado
  • +21 more
2021-11-09
Nov 9, 2021
K
Completed
  • Hypoplastic Left Heart Syndrome
  • Hypoplastic Right-sided Heart Complex
  • Ambrisentan
  • Placebo
  • Durham, North Carolina
    Duke Universtiy Hospital
2019-08-20
Aug 20, 2019
C
Recruiting
  • COVID-19
  • Cambridge, Cambridgeshire, United Kingdom
    Cambridge University Hospitals NHS Foundation Trust
2021-06-09
Jun 9, 2021
A
Completed
  • Sickle Cell Anemia
  • Ambrisentan
  • Placebo
  • Augusta, Georgia
    Augusta University
2020-04-01
Apr 1, 2020
R
Recruiting
  • Pulmonary Arterial Hypertension
  • Shanghai, China
    Renji Hospital
2020-08-22
Aug 22, 2020
M
Terminated
  • Pulmonary Arterial Hypertension
  • Ambrisentan
  • New Orleans, Louisiana
  • +1 more
2019-04-05
Apr 5, 2019
G
Completed
  • Pulmonary Hypertension
  • Ambrisentan
  • Birmingham, Alabama
  • +45 more
2020-09-08
Sep 8, 2020
H
Completed
  • Systemic Sclerosis
  • Pulmonary Hypertension
  • Ambrisentan
  • Placebo
  • Heidelberg, Germany
    Thoraxclinic at the University of Heidelberg
2020-04-17
Apr 17, 2020
U
Completed
  • Systemic Sclerosis
  • Scleroderma
  • Ambrisentan
  • Philadelphia, Pennsylvania
    University of Pennsylvania Health System
2018-11-26
Nov 26, 2018
M
Completed
  • Sarcoidosis
  • Pulmonary Hypertension
  • Ambrisentan
  • Chapel Hill, North Carolina
  • +1 more
2018-07-31
Jul 31, 2018
W
Completed
  • Single Ventricle Fontan Palliation
  • Ambrisentan
  • Saint Louis, Missouri
    Washington University School of Medicine
2018-05-04
May 4, 2018
B
Completed
  • Exercise-induced Pulmonary Arterial Hypertension
  • Ambrisentan
  • Boston, Massachusetts
    Brigham and Women's Hospital
2017-04-13
Apr 13, 2017
G
Completed
  • Vascular Disease
  • ambrisentan
  • Harbin, Heilongjiang, China
  • +11 more
2017-05-09
May 9, 2017
S
Completed
  • n Ulcer
  • Scleroderma, Systemic
  • Ambrisentan
  • Stanford, California
    Stanford University School of Medicine
2017-03-01
Mar 1, 2017
M
Withdrawn
  • Portopulmonary Hypertension
  • ambrisentan
  • Graz, Austria
    Medical University of Graz
2016-06-16
Jun 16, 2016
G
Completed
  • Hypertension, Pulmonary
  • ambrisentan
  • Darlinghurst, New South Wales, Australia
  • +112 more
2017-03-21
Mar 21, 2017